These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10695034)

  • 21. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
    Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
    Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Docosahexaenoic Acid (DHA) on Cognitive Functions in Psychiatric Disorders.
    Ciappolino V; Mazzocchi A; Botturi A; Turolo S; Delvecchio G; Agostoni C; Brambilla P
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30986970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. n-3 Fatty acids and mood: the devil is in the detail.
    Richardson AJ
    Br J Nutr; 2008 Feb; 99(2):221-3. PubMed ID: 17919344
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
    de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omega-3 fatty acids in the treatment of psychiatric disorders.
    Peet M; Stokes C
    Drugs; 2005; 65(8):1051-9. PubMed ID: 15907142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?
    Knöchel C; Voss M; Grüter F; Alves GS; Matura S; Sepanski B; Stäblein M; Wenzler S; Prvulovic D; Carvalho AF; Oertel-Knöchel V
    Curr Neuropharmacol; 2015; 13(5):663-80. PubMed ID: 26467414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Omega-3 and omega-6 polyunsaturated fatty acids: Dietary sources, metabolism, and significance - A review.
    Saini RK; Keum YS
    Life Sci; 2018 Jun; 203():255-267. PubMed ID: 29715470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.
    Freeman MP; Hibbeln JR; Wisner KL; Davis JM; Mischoulon D; Peet M; Keck PE; Marangell LB; Richardson AJ; Lake J; Stoll AL
    J Clin Psychiatry; 2006 Dec; 67(12):1954-67. PubMed ID: 17194275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 Use in Psychiatry: Evidence-Based or Elegance-Based?
    Naguy A
    J Diet Suppl; 2018 Jan; 15(1):124-128. PubMed ID: 28558251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of three rapeseed oil-rich diets, fortified with alpha-linolenic acid, eicosapentaenoic acid or docosahexaenoic acid on the composition and oxidizability of low-density lipoproteins: results of a controlled study in healthy volunteers.
    Egert S; Somoza V; Kannenberg F; Fobker M; Krome K; Erbersdobler HF; Wahrburg U
    Eur J Clin Nutr; 2007 Mar; 61(3):314-25. PubMed ID: 16969378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Omega-3 Polyunsaturated Fatty Acid Deficiency and Progressive Neuropathology in Psychiatric Disorders: A Review of Translational Evidence and Candidate Mechanisms.
    McNamara RK; Almeida DM
    Harv Rev Psychiatry; 2019; 27(2):94-107. PubMed ID: 30633010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids.
    Kidd PM
    Altern Med Rev; 2007 Sep; 12(3):207-27. PubMed ID: 18072818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of omega-3 fatty acids in psychiatry.
    McNamara RK
    Prostaglandins Leukot Essent Fatty Acids; 2006; 75(4-5):223-5. PubMed ID: 16930969
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of long-chain polyunsaturated fatty acid supplementation on neurodevelopment in childhood: a review of human studies.
    Ryan AS; Astwood JD; Gautier S; Kuratko CN; Nelson EB; Salem N
    Prostaglandins Leukot Essent Fatty Acids; 2010; 82(4-6):305-14. PubMed ID: 20188533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 polyunsaturated fatty acids and anxiety disorders.
    Ross BM
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):309-12. PubMed ID: 19906519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. n-3 fatty acids: role in neurogenesis and neuroplasticity.
    Crupi R; Marino A; Cuzzocrea S
    Curr Med Chem; 2013; 20(24):2953-63. PubMed ID: 23746276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 fatty acids in ADHD and related neurodevelopmental disorders.
    Richardson AJ
    Int Rev Psychiatry; 2006 Apr; 18(2):155-72. PubMed ID: 16777670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Omega-3 Polyunsaturated Fatty Acids as Augmentation Therapy in Treatment-Resistant Schizophrenia.
    Cuéllar-Barboza AB; Sánchez-Ruiz JA; Corral PM
    Prim Care Companion CNS Disord; 2017 May; 19(3):. PubMed ID: 28472557
    [No Abstract]   [Full Text] [Related]  

  • 39. Essential fatty acids and psychiatric disorders.
    Perica MM; Delas I
    Nutr Clin Pract; 2011 Aug; 26(4):409-25. PubMed ID: 21775637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.